Company Filing History:
Years Active: 2018
Title: Geraldine O'Hara: Innovator in Malaria Vaccine Development
Introduction
Geraldine O'Hara is a prominent inventor based in Oxfordshire, GB. She has made significant contributions to the field of immunology, particularly in the development of vaccines against malaria. Her innovative work has the potential to impact global health positively.
Latest Patents
Geraldine O'Hara holds a patent for "Simian adenoviral vectors encoding malaria antigen." This invention provides recombinant adenoviral vectors capable of eliciting immunity against the pre-erythrocytic stage of the malaria parasite's life cycle. Specifically, the invention features a recombinant, replication-deficient simian adenoviral vector that encodes an antigen comprising the thrombospondin-related adhesion protein (TRAP). Additionally, it includes immunogenic compositions, such as vaccines, that utilize this vector and methods for their application.
Career Highlights
Geraldine O'Hara has established herself as a key figure in the field of vaccine research. Her work at GlaxoSmithKline Biologicals SA has been instrumental in advancing the understanding and development of malaria vaccines. With her innovative approach, she has contributed to the scientific community's efforts to combat this devastating disease.
Collaborations
Geraldine has collaborated with notable colleagues, including Arturo Reyes and Adrian Vivian Hill. These partnerships have fostered a collaborative environment that enhances research and development in the field of immunology.
Conclusion
Geraldine O'Hara's contributions to malaria vaccine development exemplify her dedication to improving global health through innovation. Her work continues to inspire future advancements in the field of immunology.